Paris - Delayed Quote EUR

Adocia SA (ADOC.PA)

4.8750
+0.0200
+(0.42%)
As of 9:06:19 AM GMT+2. Market Open.
Currency in EUR All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
9,321
9,321
2,150
11,447
1,444
Cost of Revenue
1,120
1,120
765
1,839
1,264
Gross Profit
8,201
8,201
1,385
9,608
180
Operating Expense
15,603
15,603
15,629
11,305
19,545
Operating Income
-7,402
-7,402
-14,244
-1,697
-19,365
Net Non Operating Interest Income Expense
-1,071
-1,071
-1,261
-2,443
-2,259
Pretax Income
-8,369
-8,369
-21,160
-6,425
-22,754
Tax Provision
952
952
2
476
0
Net Income Common Stockholders
-9,321
-9,321
-21,162
-6,901
-22,754
Diluted NI Available to Com Stockholders
-9,321
-9,321
-21,162
-6,901
-22,754
Basic EPS
-1.00
-1.00
-1.90
-0.90
-3.20
Diluted EPS
-1.00
-1.00
-1.90
-0.90
-3.20
Basic Average Shares
14,808.0590
14,808.0590
14,087.3830
8,031.5270
7,057.6000
Diluted Average Shares
14,808.0590
14,808.0590
14,087.3830
8,031.5270
7,057.6000
Total Operating Income as Reported
-7,404
-7,404
-14,244
-1,698
-19,366
Total Expenses
16,723
16,723
16,394
13,144
20,809
Net Income from Continuing & Discontinued Operation
-9,321
-9,321
-21,162
-6,901
-22,754
Normalized Income
-9,321
-9,321
-16,972.5000
-5,093.5000
-21,449
Interest Income
23
23
83
28
1
Interest Expense
961
961
1,308
2,292
2,249
Net Interest Income
-1,071
-1,071
-1,261
-2,443
-2,259
EBIT
-7,408
-7,408
-19,852
-4,133
-20,505
EBITDA
-6,913
-6,913
-19,353
-3,576
-19,490
Reconciled Cost of Revenue
1,120
1,120
765
1,839
1,264
Reconciled Depreciation
495
495
499
557
1,015
Net Income from Continuing Operation Net Minority Interest
-9,321
-9,321
-21,162
-6,901
-22,754
Total Unusual Items Excluding Goodwill
0
0
-5,586
-2,410
-1,305
Total Unusual Items
0
0
-5,586
-2,410
-1,305
Normalized EBITDA
-6,913
-6,913
-13,767
-1,166
-18,185
Tax Rate for Calcs
0.0003
0.0003
0.0003
0.0003
0
Tax Effect of Unusual Items
0
0
-1,396.5000
-602.5000
0
12/31/2021 - 2/20/2012

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

POXEL.PA Poxel S.A.
0.4200
+4.24%
 
NANO.PA Nanobiotix S.A.
3.3750
+0.30%
 
IPH.PA Innate Pharma S.A.
1.9760
-0.72%
 
MEDCL.PA MedinCell S.A.
15.18
+0.87%
 
ALCLS.PA Cellectis S.A.
1.3300
-0.15%
 
ABVX.PA ABIVAX Société Anonyme
5.43
-1.27%
 
NWRN.SW Newron Pharmaceuticals S.p.A.
8.28
+1.35%
 
ALSEN.PA Sensorion SA
0.3690
-0.54%
 
GLPG.VI Galapagos NV
23.56
+1.73%
 
ALINT.PA IntegraGen SA
0.6000
0.00%